Top

Published in:

Open Access 01-12-2016 | Letter

Lack of association between bovine leukemia virus and breast cancer in Chinese patients

Authors: Rong Zhang, Jingting Jiang, Weihong Sun, Jilei Zhang, Ke Huang, Xuewen Gu, Yi Yang, Xiulong Xu, Yufang Shi, Chengming Wang

Published in: Breast Cancer Research | Issue 1/2016

Excerpt

Since Francis Peyton Rous’s landmark study of identifying avian oncogenic virus, seven viruses have been found to cause 10–15 % of human cancers worldwide [1]. Recent findings by Buehring’s group have suggested that another virus, bovine leukemia virus (BLV) – which is highly prevalent in cows worldwide [2] – might be linked to human breast cancer [3‐5]. In a study of 218 women from four states in the USA, Buehring’s group showed that the BLV positivity in women with breast cancer (67/114) is significantly higher than that in women without breast cancer (30/104) [4]. …

Rous P. A transmissible avian neoplasm (sarcoma of the common fowl). J Exp Med. 1910;12(5):696–705.

Yang Y, Fan W, Mao Y, Yang Y, Fan W, Mao Y, et al. Bovine leukemia virus infection in cattle of China: association with reduced milk production and increased somatic cell score. J Dairy Sci. 2016;99(5):3688–97.CrossRefPubMed

Buehring GC, Shen HM, Jensen HM, Choi KY, Sun D, Nuovo G. Bovine leukemia virus DNA in human breast tissue. Emerg Infect Dis. 2014;20:772–82.CrossRefPubMedPubMedCentral

Buehring GC, Shen HM, Jensen HM, Jin DL, Hudes M, Block G. Exposure to bovine leukemia virus is associated with breast cancer: a case–control study. PLoS One. 2015;10(9):e0134304.CrossRefPubMedPubMedCentral

Sinha G. Bovine leukemia virus possibly linked to breast cancer. J Natl Cancer Inst. 2016;108(2). https://www.ncbi.nlm.nih.gov/pubmed/?term=Bovine+leukemia+virus+possibly+linked+to+breast+cancer.

Title: Lack of association between bovine leukemia virus and breast cancer in Chinese patients
Authors: Rong Zhang
Jingting Jiang
Weihong Sun
Jilei Zhang
Ke Huang
Xuewen Gu
Yi Yang
Xiulong Xu
Yufang Shi
Chengming Wang
Publication date: 01-12-2016
Publisher: BioMed Central
Published in: Breast Cancer Research / Issue 1/2016
Electronic ISSN: 1465-542X
DOI: https://doi.org/10.1186/s13058-016-0763-8

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

ACC 2024 Congress

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2016

Impact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trial

Psychological stress, adverse life events and breast cancer incidence: a cohort investigation in 106,000 women in the United Kingdom

Proteomic analysis of breast tumors confirms the mRNA intrinsic molecular subtypes using different classifiers: a large-scale analysis of fresh frozen tissue samples

High mammographic breast density predicts locoregional recurrence after modified radical mastectomy for invasive breast cancer: a case-control study

High content screening application for cell-type specific behaviour in heterogeneous primary breast epithelial subpopulations

Predicted 25-hydroxyvitamin D in relation to incidence of breast cancer in a large cohort of African American women

Keynote webinar | Spotlight on antibody–drug conjugates in cancer